I INSM
Insmed Inc
BIOTECHNOLOGY · HEALTHCARE
Insmed Inc. is a biopharmaceutical company based in Bridgewater, New Jersey, that specializes in developing innovative therapies for patients with rare and serious diseases, particularly in the realms of pulmonary and infectious diseases. The company's lead product, ARIKAYCE, offers a vital treatmen...
$109.53
+1.50% (+$1.62)
Volume
3.69M
52W High
$212.75
52W Low
$64.85
Market Cap
$29.59B
Next Earnings Report
Last Reported
May 7, 2026 Beat
Actual: -$0.76
vs. Consensus: -$0.93
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
May 7, 2026
1-Day:
-3.48%
5-Day:
+10.48%
Q1 2026
Apr 30, 2026
1-Day:
-2.25%
5-Day:
+2.28%
Q4 2025
Feb 19, 2026
1-Day:
+2.43%
5-Day:
-1.48%
Q3 2025
Oct 30, 2025
1-Day:
-2.38%
5-Day:
-5.90%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q1'26 | $306.0M | +229.6% | 84.5% | -64.8% | -$163.6M |
| Q4'25 | $263.8M | +152.6% | 83.2% | -94.6% | -$328.5M |
| Q3'25 | $142.3M | +52.4% | 79.4% | -257.1% | -$370.0M |
| Q2'25 | $107.4M | +18.9% | 73.9% | -291.3% | -$321.7M |
| Q1'25 | $92.8M | +22.9% | 77.1% | -267.3% | -$256.6M |
| Q4'24 | $104.4M | +24.8% | 75.0% | -220.6% | -$235.5M |
| Q3'24 | $93.4M | +18.2% | 77.3% | -228.5% | -$220.5M |
| Q2'24 | $90.3M | +17.0% | 76.8% | -319.8% | -$300.6M |
Company Information
Symbol
INSM
Company
Insmed Inc
Market Cap
$29.59B
Sector
HEALTHCARE
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in BIOTECHNOLOGY
Compare INSM with competitors
Side-by-side earnings comparison